Aliso Viejo, California
United States
17
2019-01-31
The entities that hold a legal rights for patent applications filed by inventor Chatterton Jon E.:
Jon E. Chatterton from Aliso Viejo, US has applied for patents for these inventions. The list has both pending applications and granted patents:
RNAi-Mediated Inhibition of Tumor Necrosis Factor Alpha-Related Conditions
#2 | 2017-03-16RNAi-Mediated Inhibition of Frizzled Related Protein-1 for Treatment of Glaucoma
#3 | 2017-03-02LOW DENSITY LIPOPROTEIN RECEPTOR-MEDIATED siRNA DELIVERY
#4 | 2017-01-12RNAi-mediated inhibition of connexin 43 for treatment of IOP-related conditions
#5 | 2016-12-22RNAi-Mediated Inhibition of Tumor Necrosis Factor Alpha-Related Conditions
#6 | 2016-11-10RNAi-Related Inhibition of TNF-alpha Signaling Pathway for Treatment of Ocular Angiogenesis
#7 | 2016-06-02Low density lipoprotein receptor-mediated siRNA delivery
#8 | 2016-01-07RNAi-mediated inhibition of connexin 43 for treatment of IOP-related conditions
#9 | 2015-12-03RNAi-related inhibition of TNF-alpha signaling pathway for treatment of ocular angiogenesis
#10 | 2015-10-29RNAI-mediated inhibition of frizzled related protein-1 for treatment of glaucoma
#11 | 2015-06-18RNAi-MEDIATED INHIBITION OF HIF1A FOR TREATMENT OF OCULAR ANGIOGENESIS
#12 | 2015-06-18Low density lipoprotein receptor-mediated siRNA delivery
#13 | 2015-02-26RNAi-RELATED INHIBITION OF TNF alpha SIGNALING PATHWAY FOR TREATMENT OF GLAUCOMA
#14 | 2014-12-11RNAi-MEDIATED INHIBITION OF IGF1R FOR TREATMENT OF OCULAR ANGIOGENESIS
#15 | 2014-12-04RNAi-related inhibition of TNF alpha signaling pathway for treatment of ocular angiogenesis
#16 | 2014-12-04RNAi-mediated inhibition of tumor necrosis factor α-related conditions
#17 | 2014-07-17RNAi-MEDIATED INHIBITION OF SELECT RECEPTOR TYROSINE KINASES FOR TREATMENT OF PATHOLOGIC OCULAR NEOVASCULARIZATION-RELATED CONDITIONS
840006 ⎘